Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain
- PMID: 33445523
- PMCID: PMC7826730
- DOI: 10.3390/v13010093
Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain
Abstract
The extraordinary genetic variability of human immunodeficiency virus type 1 (HIV-1) group M has led to the identification of 10 subtypes, 102 circulating recombinant forms (CRFs) and numerous unique recombinant forms. Among CRFs, 11 derived from subtypes B and C have been identified in China, Brazil, and Italy. Here we identify a new HIV-1 CRF_BC in Northern Spain. Originally, a phylogenetic cluster of 15 viruses of subtype C in protease-reverse transcriptase was identified in an HIV-1 molecular surveillance study in Spain, most of them from individuals from the Basque Country and heterosexually transmitted. Analyses of near full-length genome sequences from six viruses from three cities revealed that they were BC recombinant with coincident mosaic structures different from known CRFs. This allowed the definition of a new HIV-1 CRF designated CRF108_BC, whose genome is predominantly of subtype C, with four short subtype B fragments. Phylogenetic analyses with database sequences supported a Brazilian ancestry of the parental subtype C strain. Coalescent Bayesian analyses estimated the most recent common ancestor of CRF108_BC in the city of Vitoria, Basque Country, around 2000. CRF108_BC is the first CRF_BC identified in Spain and the second in Europe, after CRF60_BC, both phylogenetically related to Brazilian subtype C strains.
Keywords: HIV-1; HIV-1 genetic diversity; HIV-1 molecular epidemiology; HIV-1 phylogeny; circulating recombinant form.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Gryseels S., Watts T.D., Mpolesha J.M.K., Larsen B.B., Lemey P., Muyembe-Tamfum J.J., Teuwen D.E., Worobey M. A near full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue. Proc. Natl. Acad. Sci. USA. 2020;117:12222–12229. doi: 10.1073/pnas.1913682117. - DOI - PMC - PubMed
-
- Hemelaar J., Elangovan R., Yun J., Dickson-Tetteh L., Fleminger I., Kirtley S., Williams B., Gouws-Williams E., Ghys P.D., Abimiku A.G., et al. Global and regional molecular epidemiology of HIV-1, 1990–2015: A systematic review, global survey, and trend analysis. Lancet Infect. Dis. 2019;19:143–155. doi: 10.1016/S1473-3099(18)30647-9. - DOI - PubMed
-
- Hofstra L.M., Sauvageot N., Albert J., Alexiev I., García F., Struck D., Van De Vijver D.A.M.C., Åsjö B., Kolupajeva T., Kostrikis L.G., et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clin. Infect. Dis. 2016;62:655–663. doi: 10.1093/cid/civ963. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
